Depreciation Amortization - Xeris Biopharma Holdings Inc (NASDAQ:XERS) - Alpha Spread

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 2.965 USD -0.5% Market Closed
Market Cap: 439.6m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

Xeris Biopharma Holdings Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Xeris Biopharma Holdings Inc
Depreciation & Amortization Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Depreciation & Amortization
-$10.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Depreciation & Amortization
-$9.3B
CAGR 3-Years
3%
CAGR 5-Years
-169%
CAGR 10-Years
-60%
Pfizer Inc
NYSE:PFE
Depreciation & Amortization
-$5.1B
CAGR 3-Years
-41%
CAGR 5-Years
N/A
CAGR 10-Years
-2%
Merck & Co Inc
NYSE:MRK
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Xeris Biopharma Holdings Inc's Depreciation & Amortization?
Depreciation & Amortization
-10.8m USD

Based on the financial report for Jun 30, 2024, Xeris Biopharma Holdings Inc's Depreciation & Amortization amounts to -10.8m USD.

What is Xeris Biopharma Holdings Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 1Y
0%

Over the last year, the Depreciation & Amortization growth was 0%.

Back to Top